Getinge stock

GETI.B · Nasdaq Stockholm · SEK

Compare Getinge
kr 276.80Change from previous close: −1.14%Absolute change: −kr 3.20

Close · November 20, 2026

Price history

+33.98% over the period

1 year: from kr 206.60 (November 20, 2025) to kr 276.80 (November 20, 2026), +33.98%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026kr 276.80
October 30, 2026kr 277.70
September 30, 2026kr 248.00
August 31, 2026kr 243.90
July 31, 2026kr 237.40
June 30, 2026kr 198.10
May 29, 2026kr 189.85
April 30, 2026kr 183.55
March 31, 2026kr 188.55
February 27, 2026kr 202.90
January 30, 2026kr 195.40
December 30, 2025kr 218.80
November 28, 2025kr 214.90
November 20, 2025kr 206.60

At a glance

  • The company

    Provides medical equipment and sterilization solutions for operating rooms, intensive care units and surgical workflows globally

  • Latest results

    Quarter to September 30, 2026 · EPS kr 3.10 (estimate kr 2.51)

TickerLandia's take on Getinge

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 175.90
52-wk highkr 283.80

−2.47% from the 52-week high

Analysts · 11 analysts

Average targetkr 272.91−1.41% vs. price

Buy 4 · Hold 6 · Sell 1

TickerLandia Fingerprint: Getinge

Compared with similar companies: very strong momentum.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Getinge is pricier than in the past and cheaper than similar companies

On the latest fiscal year's earnings (2025), Getinge's P/E today is 33.4, above the median of its last 9 fiscal years (27.2; between 16.2 and 38.8 from 2016 to 2025). Getinge's P/E (trailing 12 months): 26.6, −10% against the median of a group of 10 similar companies (29.5).

P/E compared with its history

Compared with 10 similar companies

Getinge's metrics compared with similar companies
MetricGetingePosition in the groupBand
P/E (trailing 12 months)26.6Low
Forward P/E25.3Middle
Operating margin14.3%Middle
ROE9.1%Middle
Debt/equity0.34Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Getinge. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 8.45B

Latest quarter · Q3 2026

Net income

kr 719M

Latest quarter · Q3 2026

Quarterly net margin

8.5%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
kr 75.39B
P/E
26.6
EPS
kr 10.39
Volume
337.13K
Daily trading
€11.12M
Dividend yield
1.72%
Last ex-dividend on April 22, 2026

How Getinge is changing

All results
  • Revenue grew 3.2% a year on average over the last 5 years

  • Profits turn into cash: free cash flow equal to 145% of net income

  • Revenue has grown for 4 fiscal years in a row

Returns

Getinge returns with dividends

kr 1,000 invested in Getinge 5 years ago, on November 22, 2021, would be worth kr 753 today with dividends reinvested: −24.75% in total, −5.53% per year. On price alone it would be kr 682 (−31.76%).

PeriodGetingekr 1,000 becomes
1 month+6.58%kr 1,066
6 months+40.54%kr 1,405
Year to date+26.51%kr 1,265
1 year+37.23%kr 1,372
3 years+34.37%kr 1,344
5 years−24.75%kr 753
10 years+220.52%kr 3,205

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Getinge: technical analysis

Getinge is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 35.5% below its all-time closing high (kr 429.40, November 15, 2021).

Trend
Upward
RSI (14 sessions)
57
Between 30 and 70
vs 200-session average
+25.62%

Support and resistance

Price areas where Getinge has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last pricekr 276.80
  3. Supportkr 247.60−10.55%3 touches, last on September 7, 2026
  4. Supportkr 242.85−12.27%2 touches, last on October 6, 2026
  5. Supportkr 235.20−15.03%3 touches, last on September 11, 2026

Volatility and risk

Volatility (60 sessions, annualised)
18.1%
Largest fall in the last year
−20.72%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Getinge: seasonality

Average monthly price change over 27 years

+4.2%Jan+1.4%Feb+0.2%Mar+1.4%Apr+0.1%May−1.5%Jun+4.6%Jul+0.1%Aug−1.2%Sep+2.1%Oct+2.3%Nov+1.6%Dec

Over the last 27 years, the strongest month for Getinge has been July: +4.59% on average, positive in 18 years out of 27. The weakest has been June: −1.45% on average, positive in 11 years out of 27. November, the current month, has been positive in 17 years out of 26 (+2.26% on average).

Show chart data
MonthAverageMedianPositive years
January+4.19%+5.00%15 of 26
February+1.44%+1.38%14 of 27
March+0.22%+0.71%14 of 27
April+1.39%−0.65%13 of 27
May+0.10%+1.43%15 of 27
June−1.45%−1.39%11 of 27
July+4.59%+3.81%18 of 27
August+0.06%−1.19%13 of 27
September−1.19%+0.46%14 of 27
October+2.07%+6.94%16 of 27
November+2.26%+2.74%17 of 26
December+1.63%+2.19%17 of 26

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Getinge and its competitors

Sales reach customers in the Americas, Europe, the Middle East, Africa, and Asia and Pacific, through a network of the company's own sales companies as well as through agents and distributors. The product range covers extracorporeal membrane oxygenation, mechanical ventilation, patient monitoring and drainage systems, along with cardiac and vascular surgery equipment, peripheral stenting, and anesthesia and operating room integration.

Headquarters
Gothenburg, Sweden
Employees
11,847
Founded
1904
Chief executive
Mattias Perjos
Getinge and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
GetingeGETI.B$7.39B14.3%26.6+40.54%
SectraSECT.B$6.24B20.6%105.8+21.58%
DemantDEMANT$10.7B17.2%30.1+44.56%
Smith & NephewSN.$12.57B14.2%20.80.00%
AmbuAMBU.B$3.4B13.2%36.7+32.33%
Sonova HoldingSOON$20.67B20.6%28.9+43.74%

Same industry or related industries, similar size. Compare Getinge with its competitors · Full profile